Tools & Techniques
| 5 min read
Where most ELNs store records in isolation, Genedata's new embedded ELN shares a data model with molecules, samples, and assays across the platform
Explore how enzymatic DNA synthesis can support longer, more complex constructs for genome editing, mRNA, and synthetic biology workflows.
| 4 min read
A new GMP-grade defined medium raises a ninefold EV yield — and provides the manufacturing documentation clinical programs need to advance
| 6 min read
VivoSim's NAMkind platform puts drug candidates into contact with diseased human donor tissue, asking whether they work in MASH and IBD before anyone enrolls
| 4 min read
OGT's first dedicated fusion MRD NGS panel targets the roughly one-quarter of AML cases where RNA fusion transcripts, not DNA mutations, define residual disease
| 3 min read
Growing evidence supports the use of virtual controls in toxicology, but their broader adoption will depend on rigorous data curation, pathology expertise, and robust validation.
Explore a strategic guide to IND-enabling nonclinical development for small molecules and biologics.
| 1 min read
BPS Bioscience’s FluoSite™ fluorescent-labeled antibodies offer a streamlined approach to sensitive and reproducible flow cytometry experiments.
| 5 min read
Two new UG200 capabilities (doubled per-wafer output and paired-end reads) position Ultima's platform for germline whole genome sequencing at a stated $60
Discover how researchers are looking beyond individual neurons to understand how genetic variations shape activity across brain organoid networks.
| 2 min read
Refeyn’s TwoMP accelerates mRNA therapeutic development by replacing slow, sample-intensive assays with rapid, label-free single-molecule native analysis.
| 5 min read
ScionxBio's Sanofi deal is a bet that AI-guided chemistry can push mRNA protein expression from days to weeks, opening new ground in chronic disease
